25th Nov 2011 15:55
For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are Verona Pharma Plc
attached:ii
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result
in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the FIL Limited
notification obligation:iii
4. Full name of shareholder(s) See attached schedule
(if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or 18 November 2011
reached: v
6. Date on which issuer notified: 24 November 2011 7. Threshold(s) that is/are crossed or 5%
reached: vi, vii 8. Notified details:
A: Voting rights attached to shares viii, ix Class/type of Situation previous Resulting situation after the triggering transaction shares to the triggering transaction if possible Number Number Number Number of voting % of voting rights x using of of of shares rights the ISIN CODE Shares Voting Rights Indirect Direct xi Indirect Direct Indirect xii GB00B06GSH43 12,224,579 12,224,579 12,024,579 12,024,579 4.96
B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date xiii Conversion Period xiv rights that may be rights acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of voting rights % of voting rights instrument price date xvii Conversion instrument refers to xix, xx period xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 12,024,579 4.96
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
See attached schedule Proxy Voting: 10. Name of the proxy holder: FIL Limited
11. Number of voting rights proxy holder will cease to 200,000
hold:
12. Date on which proxy holder will cease to hold of 24 November 2011
voting rights: 13. Additional information: None 14. Contact name: Philip Alexander 15. Contact telephone number: [email protected] /
01737 834624
XLONRelated Shares:
VRP.L